This innovative collaboration with Patient Choice Laboratories utilizes molecular testing for the swift and precise identification of pathog

PCL has launched its proprietary test for xylazine to help providers prevent intoxication with the very dangerous and potent synthetic...

Patient Choice Laboratories' Molecular Team published a study over the detection of respiratory viruses using a multiplex assay.

Patients Choice Laboratories acquires Infinity Laboratories to better provide testing services to providers in the southern U.S.

The CAP Accreditation is awarded to laboratories that meet stringent requirements and maintain the highest standards of laboratory quality.

Dr. Rojeet Shresta, Technical Director for Patients Choice Laboratories, has been recognized as one of the 40 Under Forty by the American So

PCL announced today a partnership with RLL as the “Official Laboratory Partner” and associate sponsor with the team in a multi-year deal.

Patients Choice Laboratories partners with the Indiana Chamber and Wellness Council of Indiana to provide COVID testing statewide.

Patient Choice Laboratories' Molecular Team published a study over SARS-CoV-2 variant detection methods.

Pharmacogenetics (PGx) is a test that involves looking at your unique genetic makeup to understand how your body responds to medications.

INDIANAPOLIS, June 23, 2021 – Patients Choice Laboratories (PCL), a leading life sciences company, is proud to offer its PCR SARS-CoV-2...

INDIANAPOLIS, February 16, 2021 – Patients Choice Laboratories (PCL), a leading life sciences company, is proud to offer its COVID+...

INDIANAPOLIS, IN – April 16, 2020 – Patients Choice Laboratories (PCL), a leading life sciences company, has partnered with the Indiana...

INDIANAPOLIS, IN – April 14, 2020 – Patients Choice Laboratories, a leading life sciences company, is making its Novel Coronavirus...